http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1495680-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fcbc1de8801460caf80ad76627ae20b0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D303-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D303-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-54
filingDate 1975-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1977-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1495680-A
titleOfInvention 1-(2-benzoylphenoxy)-2-hydroxy-3-aminopropanes
abstract 1495680 1 - (2 - Benzoylphenoxy) - 2 - hydroxy-3-aminopropanes MAY & BAKER Ltd 16 June 1976 [20 June 1975] 26407/75 Heading C2C Novel compounds of Formula I (wherein R<SP>1</SP> represents an isopropyl, t-butyl or 2-phenylethyl group, R<SP>2</SP> represents a methyl group or a chlorine atom, n represents 1 or 2 and m represents 0, 1 or 2) and non-toxic acid addition salts thereof where it is to be understood that when m represents 2 then the substitutents represented by the symbol R<SP>2</SP> may be the same or different are prepared by reaction of a compound of Formula II with an amine R<SP>1</SP>NH 2 . Intermediates of Formula II above are prepared from compounds of Formula IV with epichlorohydrin. Phenols of Formula IV are prepared by Fries rearrangement of the substituted benzoyloxy compounds prepared by acylation of the unsubstituted phenols. Pharmaceutical compositions in conventional forms for oral or parenteral administration and having vascular #-andrenoceptor blocking activity comprise an above novel compound and a carrier or diluent.
priorityDate 1975-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456001950
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429253154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474448
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153776552
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID996

Total number of triples: 30.